*Zeinab Takalloo Bighash¹, Sonam Parakh¹, Julie D Atkin^1,2 (1. Macquarie Medical School, Macquarie University Centre for MND Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia. , 2. La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.)

*Kei Suga^1,2, Sachiko Yamamoto-Hijikata¹, Yasuo Terao², Makoto Ushimaru¹ (1. Dept. Chem. Kyorin Univ., Faculty of Med., Tokyo, JapanDept. Chem. Kyorin Univ., Faculty of Med., Tokyo, Japan, 2. Dept. Med. Physiol., Kyorin Univ., Faculty of Med., Tokyo, Japan)

*Kyoka Tsukuda^1,2, Michiko Miwa³, Makiko Taketoshi², Yoko Tominaga², Kentaro Nakashima^1,2,3, Takashi Tominaga^1,2,3 (1. Grad Sch of Pharm Sci, Tokushima Bunri Univ, Japan, 2. Inst of Neurosci, Tokushima Bunri Univ, Japan, 3. Kagawa Sch of Pharm Sci, Tokushima Bunri Univ, Japan)

*Hideki Hayakawa¹, Kousuke Baba², Hiroshi Sakiyama¹, Chi-Jing Choong¹, Yasuyoshi Kimura¹, Kensuke Ikenaka¹, Cesar Aguirre¹, Tatsusada Okuno¹, Seiichi Nagano^1,2, Yoshitaka Nagai³, Hideki Mochizuki ¹ (1. Department of Neurology, Osaka University Graduate School of Medicine , 2. Department of Neurotherapeutics, Osaka University Graduate School of Medicine, 3. Department of Neurology, Faculty of Medicine, Kindai University)

*Kazutaka Sainohira¹, Shinichiro Tagawa¹, Yoshiaki Nishizawa¹, Hanae Hiwatashi¹, Izumi Yokoyama¹, Kensuke Imamura¹, Hitoshi Sakimoto¹, Yuka Urata¹, Kaoru Arai¹, Natsuki Sasaki¹, Masayuki Nakamura (1. DEPARTMENT OF PSYCHIATRY KAGOSHIMA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES)

*Yukiko Hori¹, Takanobu Suzuki¹, Taka Sawazaki^2,3, Makoto Higuchi⁴, Youhei Sohma^2,3, Motomu Kanai², Taisuke Tomita¹ (1. Lab. of Neuropathology and Neuroscience, Grad. Sch. Pharm. Sci., Univ. of Tokyo, Japan, 2. Lab. of Synthetic Organic Chemistry, Grad. Sch. Pharm. Sci., Univ. of Tokyo, Japan, 3. Dept. of Medicinal Chemistry, Sch. Pharm. Sci., Wakayama Medical Univ., Japan, 4. Dept. of Functional Brain Imaging, QST, Japan)

*Iori Ohmori¹, Mamoru Ouchida², Saeko Ishida³, Tomoji Mashimo³ (1. Okayama University, 2. Okayama University, 3. University of Tokyo)

*Sachie Hamada^1,2, Hayuma Otsuka², Hitoshi Ishibashi¹, Jun-Ichiro Oka² (1. Sch of Allied Health Sci, Kitasato Univ, Kanagawa, Japan, 2. Faculty of Pharm Sci, Tokyo Univ of Sci, Chiba, Japan)

*Hiroshi Kameda^1,2, Kakeru Ogasawara², Shinichiro Okamoto^1,2,3, Masato Koike^1,2 (1. Dept Med, Juntendo Univ, Tokyo, Japan, 2. Grad Sch Med, Juntendo Univ, Tokyo, Japan, 3. Adv Res Inst Health Sci, Juntendo Univ, Tokyo, Japan)

*Yoshino Yonezu^1,2, Shogo Tanabe¹, Hidemi Misawa², Rieko Muramatsu¹ (1. Department of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 2. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Keio University)

Noor Azzizah Omar^1,2, Jaya Kumar³, *Seong Lin Teoh¹ (1. Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia, 2. Department of Medical Sciences, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Negeri Sembilan, Malaysia, 3. Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia)

*Akira Ishiguro¹, Keiko Nishijima², Yuta Murakami³, Hiroshi kimura³, Shinji Hadano^2,4, Asako Otomo^2,4 (1. Hosei University, 2. Molecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, 3. Graduate School of Engineering, Tokai University, 4. Micro/Nano Technology Center, Tokai University)